Status | Study |
Active, not recruiting |
Study Name: Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer Condition: Recurrent Thyroid Gland Carcinoma Stage III Differentiated Thyroid Gland Carcinoma Date: 2008-02-27 Interventions: Other: Laboratory Biomarker Analysis |
Completed |
Study Name: Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer Condition: Recurrent Thyroid Cancer Stage IVA Follicular Thyroid Cancer Date: 2007-08-21 Interventions: Drug: sunitinib malate Given PO Other Names: |
Completed |
Study Name: Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer Condition: Renal Cell Cancer Kidney Cancer Date: 2007-04-20 Interventions: Drug: Sunitinib Malate 50 mg by mouth daily for 4 weeks, then 2 weeks off. |
Active, not recruiting |
Study Name: Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer Condition: Multiple Endocrine Neoplasia Recurrent Thyroid Gland Carcinoma Date: 2006-10-18 Interventions: Other: Laboratory Biomarker Analysis |
Active, not recruiting |
Study Name: Sunitinib in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery Condition: Recurrent Thyroid Gland Carcinoma Stage III Thyroid Gland Follicular Carcinoma Date: 2006-09-26 Interventions: Other: Laboratory Biomarker Analysis |
Completed |
Study Name: Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer Condition: Insular Thyroid Cancer Recurrent Thyroid Cancer Stage II F Date: 2005-08-22 Interventions: Drug: vorinostat Given orally Other Names: |
Completed |
Study Name: Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer Condition: Recurrent Thyroid Cancer Stage IV Follicular Thyroid Cancer Date: 2005-07-08 Interventions: Drug: tanespimycin Given IV Other Name: 17-AAG |
Completed |
Study Name: Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer Condition: Head and Neck Cancer Date: 2005-01-06 Interventions: Drug: irinotecan hydrochloride |
Completed |
Study Name: Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer Condition: Anaplastic Thyroid Cancer Insular Thyroid Cancer Metastati Date: 2003-09-10 Interventions: Drug: gefitinib Given orally Other Names: |
Completed |
Study Name: Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer Condition: Adenocarcinoma of the Colon Adenocarcinoma of the Gallbladder Date: 2002-01-04 Interventions: Biological: recombinant fowlpox-CEA(6D)/TRICOM vaccine |